Total Payments
$1,491
2024 Payments
$240.62
Companies
16
Transactions
54
Medicare Patients
2,084
Medicare Billing
$159,402
Payment Breakdown by Category
Food & Beverage$1,480 (99.2%)
Education$11.71 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,480 | 53 | 99.2% |
| Education | $11.71 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $559.81 | 10 | $0 (2024) |
| Novo Nordisk Inc | $279.83 | 18 | $0 (2022) |
| Lilly USA, LLC | $137.27 | 5 | $0 (2023) |
| Astellas Pharma US Inc | $117.96 | 3 | $0 (2023) |
| NESTLE HEALTHCARE NUTRITION INC. | $103.34 | 1 | $0 (2023) |
| AbbVie Inc. | $62.55 | 3 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $39.99 | 2 | $0 (2021) |
| Genentech USA, Inc. | $36.15 | 2 | $0 (2020) |
| Amarin Pharma Inc. | $32.19 | 2 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $29.65 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $240.62 | 2 | AstraZeneca Pharmaceuticals LP ($240.62) |
| 2023 | $492.75 | 9 | AstraZeneca Pharmaceuticals LP ($124.98) |
| 2022 | $204.60 | 7 | AstraZeneca Pharmaceuticals LP ($100.65) |
| 2021 | $220.07 | 13 | Novo Nordisk Inc ($45.98) |
| 2020 | $267.81 | 18 | Novo Nordisk Inc ($159.55) |
| 2018 | $42.51 | 3 | AstraZeneca Pharmaceuticals LP ($28.99) |
| 2017 | $23.03 | 2 | AstraZeneca Pharmaceuticals LP ($23.03) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $118.80 | General |
| Category: Respiratory | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $87.44 | General |
| Category: Biological | ||||||
| 09/27/2023 | NESTLE HEALTHCARE NUTRITION INC. | VOWST (Biological) | Food and Beverage | Cash or cash equivalent | $103.34 | General |
| Category: GI | ||||||
| 08/31/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Biological | ||||||
| 06/30/2023 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: WOMENS HEALTH | ||||||
| 06/22/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: DIABETES | ||||||
| 06/15/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $80.52 | General |
| Category: Diabetes | ||||||
| 05/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Respiratory | ||||||
| 05/01/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Diabetes | ||||||
| 06/09/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 05/06/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Diabetes | ||||||
| 05/05/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $100.65 | General |
| Category: Respiratory | ||||||
| 04/08/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Diabetes | ||||||
| 02/22/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Diabetes | ||||||
| 01/20/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Diabetes | ||||||
| 10/27/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: PSYCHIATRY | ||||||
| 10/20/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: PSYCHIATRY | ||||||
| 08/04/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Cardiovascular | ||||||
| 06/12/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardiovascular | ||||||
| 05/05/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 405 | 782 | $61,932 | $29,868 |
| 2022 | 12 | 582 | 1,080 | $91,404 | $48,608 |
| 2021 | 14 | 714 | 1,306 | $113,779 | $61,703 |
| 2020 | 11 | 383 | 423 | $39,999 | $19,223 |
Total Patients
2,084
Total Services
3,591
Medicare Billing
$159,402
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 124 | 290 | $46,400 | $21,077 | 45.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 31 | $6,820 | $3,133 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 38 | $4,180 | $1,812 | 43.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 117 | 235 | $1,175 | $1,142 | 97.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 20 | 27 | $945.00 | $926.10 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 41 | 86 | $1,290 | $800.24 | 62.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 21 | 46 | $552.00 | $540.96 | 98.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 12 | 12 | $485.00 | $400.02 | 82.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 17 | $85.00 | $37.40 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 408 | $63,973 | $31,692 | 49.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 47 | 47 | $7,491 | $5,769 | 77.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 24 | $5,234 | $3,275 | 62.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 40 | $4,420 | $2,441 | 55.2% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 36 | 36 | $1,570 | $1,026 | 65.3% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2022 | 44 | 100 | $2,800 | $968.58 | 34.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 37 | 37 | $957.20 | $918.06 | 95.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 145 | 296 | $1,954 | $870.14 | 44.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 12 | 29 | $1,885 | $828.29 | 43.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 15 | 16 | $560.00 | $551.95 | 98.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 18 | 18 | $270.00 | $171.36 | 63.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 20 | 29 | $290.00 | $96.81 | 33.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 165 | 448 | $69,618 | $38,039 | 54.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 54 | 54 | $7,020 | $6,822 | 97.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 67 | $7,330 | $4,507 | 61.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 41 | 41 | $9,225 | $2,910 | 31.5% |
About Dr. Mary Clapp, M.D
Dr. Mary Clapp, M.D is a Family Medicine healthcare provider based in Northport, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2013. The National Provider Identifier (NPI) number assigned to this provider is 1982041463.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Clapp, M.D has received a total of $1,491 in payments from pharmaceutical and medical device companies, with $240.62 received in 2024. These payments were reported across 54 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,480).
As a Medicare-enrolled provider, Clapp has provided services to 2,084 Medicare beneficiaries, totaling 3,591 services with total Medicare billing of $159,402. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Northport, AL
- Active Since 05/24/2013
- Last Updated 04/25/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1982041463
Products in Payments
- BREZTRI (Drug) $344.43
- Ozempic (Drug) $186.65
- FARXIGA (Drug) $163.36
- VOWST (Biological) $103.34
- Veozah (Drug) $101.68
- MOUNJARO (Drug) $80.52
- Rybelsus (Drug) $60.78
- VRAYLAR (Drug) $54.38
- BYDUREON (Drug) $52.02
- TRULICITY (Drug) $45.04
- TRINTELLIX (Drug) $39.99
- Xofluza (Drug) $36.15
- Vascepa (Drug) $32.19
- REXULTI (Drug) $29.65
- PREMARIN (Drug) $25.50
- QULIPTA (Drug) $21.01
- RYBELSUS (Drug) $18.88
- MYRBETRIQ (Drug) $16.28
- JARDIANCE (Drug) $15.19
- Tresiba (Drug) $13.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Northport
Clinton Mcentyre, M.d, M.D
Family Medicine — Payments: $20,557
Family Medicine $20,557
Scott Kemp, D.o, D.O
Family Medicine — Payments: $19,805
Family Medicine $19,805
Dr. Malika Aryanpure, M.d, M.D
Family Medicine — Payments: $10,105
Family Medicine $10,105
Dr. Caroline Day, Md, MD
Family Medicine — Payments: $10,016
Family Medicine $10,016
Ronald Harrison, Do, DO
Family Medicine — Payments: $7,099
Family Medicine $7,099
Steven Coppock, M.d, M.D
Family Medicine — Payments: $6,510
Family Medicine $6,510